Log in to search using one of your social media accounts:

 

From Genes and Cells to Saving Lives: NEJM Reports Positive Results...
Basic science from University of Colorado Cancer Center leads to clinical trial results reported in New England Journal of Medicine: Of 55 patients with TRK-fusion cancer who progressed after...(PRWeb February 22, 2018)Read the full story at http://www.prweb.com/releases/2018/02/prweb15239492.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 22, 2018 Category: Pharmaceuticals Source Type: news

YouTuber dies of cancer after claiming veganism cured it
Mari Lopez, who ran the food channel at home in Houston, Texas with her niece Liz Johnson, told viewers she had rejected traditional treatment for breast cancer in favor of a 90-day juice cleanse. (Source: the Mail online | Health)
Source: the Mail online | Health - February 21, 2018 Category: Consumer Health News Source Type: news

Just one soft drink a day could increase cancer risk, study finds
Researchers hail ‘surprising’ findings about sugar after analysing more than 3,000 casesPeople who regularly consume at least one sugary soft drink a day, no matter the size of their waist, could be at increased risk of cancer, according to a new study.Researchers from Cancer Council Victoria and University of Melbourne studied more than 35,000 Australians who developed 3,283 cases of obesity-related cancers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 21, 2018 Category: Science Authors: Australian Associated Press Tags: Sugar Soft drinks Health Cancer Obesity Melbourne Victoria Australia news Medical research Science Source Type: news

AHN's Forbes cancer center a glimpse of health system's future
Both AHN and UPMC, the two big health care providers in the Pittsburgh region, are putting more emphasis on community care, offering sophisticated treatment previously available at big-city hospitals. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 21, 2018 Category: Biotechnology Authors: Paul J. Gough Source Type: news

AHN's Forbes cancer center a glimpse of health system's future
Both AHN and UPMC, the two big health care providers in the Pittsburgh region, are putting more emphasis on community care, offering sophisticated treatment previously available at big-city hospitals. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 21, 2018 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

After-effects not necessarily reduced with robotic prostate surgery
(Reuters Health) - Men with prostate cancer who get the gland removed may be just as likely to suffer after-effects like erectile dysfunction and urinary incontinence with robotic surgery as with other operations, a UK study suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Perceived Narrowing of Racial Disparity in Prostate Cancer Outcomes Due to Screening
The observed narrowing of racial disparities in prostate cancer outcome since the advent of PSA screening is not as large as previously believed. (Source: CancerNetwork)
Source: CancerNetwork - February 21, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

Lung cancer warning - why you should never ignore dizziness
CANCER symptoms can include changes to the body ’s normal processes. But, feeling dizzy could be a sign of lung cancer, Cancer Research UK warned. (Source: Daily Express - Health)
Source: Daily Express - Health - February 21, 2018 Category: Consumer Health News Source Type: news

First Look: Allegheny Health Network's new cancer center at Forbes
Work on the center has already begun. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 21, 2018 Category: American Health Authors: Paul J. Gough Source Type: news

Online Tool Aids Decision Making About Breast Cancer Treatment
Findings based on assessment of the interactive iCanDecide tool (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 21, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news

Cigars and pipes tied to same risks as cigarettes
(Reuters Health) - Cigarettes are not the only type of tobacco products that can lead to premature death or fatalities from smoking-related cancers, a U.S. study confirms. (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional
Funding to support observational or intervention research focused on reducing cancer health disparities in tobacco use in the United States. Specifically, this FOA is intended to stimulate scientific inquiry focused on innovative tobacco control policies. (Source: PHPartners.org)
Source: PHPartners.org - February 21, 2018 Category: International Medicine & Public Health Source Type: news

Billy Graham, 'America's Pastor' Dies at 99
Internationally known evangelist Billy Graham, a counselor to presidents had been treated for cancer, pneumonia and other ailments before his death at 99. (Source: WebMD Health)
Source: WebMD Health - February 21, 2018 Category: Consumer Health News Source Type: news

When you have kidney cancer...
There's one important thing to remember, when you've been diagnosed with kidney cancer. What is it?02/21/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 21, 2018 Category: Urology & Nephrology Source Type: news

Medical News Today: How one enzyme could stop the spread of cancer
A study reveals that activation of the enzyme RIPK1 can trigger cell death in cancer cells poised to migrate by causing them to degrade their mitochondria. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 21, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Can you vaccinate yourself against cancer?
Studies touting the benefits of cancer vaccines are emerging, but do those studies really show hope or just hype? Here's a look at the past, present and future of cancer vaccine research. (Source: CNN.com - Health)
Source: CNN.com - Health - February 21, 2018 Category: Consumer Health News Source Type: news

Cancer vaccines: Where do we stand?
Studies touting the benefits of cancer vaccines are emerging, but do those studies really show hope or just hype? Here's a look at the past, present and future of cancer vaccine research. (Source: CNN.com - Health)
Source: CNN.com - Health - February 21, 2018 Category: Consumer Health News Source Type: news

' Unrealistic Expectations' for Cancer Survivorship Care Plans'Unrealistic Expectations' for Cancer Survivorship Care Plans
In the current literature, there is limited evidence of benefit from survivorship care plans. Researchers are calling for a shift in the focus of current research.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Kenya:MoH Partners With Johnson & Johnson to Aid Cancer Control Strategy
[Capital FM] Kisumu -The Ministry of Health has stepped up ongoing efforts to raise awareness on the National Cancer Control Strategy 2017-2022. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 21, 2018 Category: African Health Source Type: news

Doctors In China Lead Race To Treat Cancer By Editing Genes
More than a third of patients with cancer of the esophagus responded to experimental treatment in China with the gene-editing technique CRISPR. Several CRISPR studies are underway there.(Image credit: Yuhan Xu/NPR) (Source: NPR Health and Science)
Source: NPR Health and Science - February 21, 2018 Category: Consumer Health News Authors: Rob Stein Source Type: news

Woman's cancer ate away her ribs like 'a caterpillar'
In February 2012, Catherine Cook, 55, from Suffolk, began experiencing tight pains in her chest and shoulder, which intensified over the next six months. By June, she was in agony. (Source: the Mail online | Health)
Source: the Mail online | Health - February 21, 2018 Category: Consumer Health News Source Type: news

How is ovarian cancer detected? If you have the signs and symptoms take this test
OVARIAN cancer symptoms can be difficult to recognise, particularly in the early stages, but if you ’ve experienced bloating most days for the last three weeks, you may want to look out for other signs and consider visiting your GP for a test. (Source: Daily Express - Health)
Source: Daily Express - Health - February 21, 2018 Category: Consumer Health News Source Type: news

Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6%. The transaction is expected to close in the first half of 2018. (Source: World Pharma News)
Source: World Pharma News - February 21, 2018 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc.
CARY, N.C. (February 21, 2018) —Biologics, Inc., a McKesson Specialty Health oncology and complex care pharmacy services company, has been selected by the Janssen Pharmaceutical Companies of Johnson& Johnson1  to be in the limited distribution network for ERLEADA™ (apalutamide), the first FDA-approv... (Source: McKesson News)
Source: McKesson News - February 21, 2018 Category: Information Technology Source Type: news

Facial Cancer Decimating Tasmanian Devil Population
Title: Facial Cancer Decimating Tasmanian Devil PopulationCategory: Health NewsCreated: 2/20/2018 12:00:00 AMLast Editorial Review: 2/21/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 21, 2018 Category: Cancer & Oncology Source Type: news

Newer Breast MRI May Be More Accurate and Easier
Title: Newer Breast MRI May Be More Accurate and EasierCategory: Health NewsCreated: 2/20/2018 12:00:00 AMLast Editorial Review: 2/21/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 21, 2018 Category: Cancer & Oncology Source Type: news

Mirada introduces AI software for radiation oncology
Imaging software developer Mirada Medical has introduced DLCExpert, a software...Read more on AuntMinnie.comRelated Reading: Optellum, Mirada present lung cancer study at RSNA 2017 Mirada's deep-learning contours match human-drawn contours Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2018 Category: Radiology Source Type: news

Densitas highlights study in Breast Cancer Research
Medical software developer Densitas is directing attention to a recent review...Read more on AuntMinnie.comRelated Reading: Densitas deploys breast density software throughout Canada Densitas touts breast density clinical research Densitas accepted into JLABS @ Toronto Densitas highlights breast density research at ECR Densitas receives CE Mark, Canadian clearance (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2018 Category: Radiology Source Type: news

MD Anderson receives $22 million in CPRIT funding for research, prevention and recruitment
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30 percent of the $73.5 million in awards CPRIT announced today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Precision cancer therapy effective in both children and adults
(Children's Hospital Los Angeles) Three quarters of patients, both adults and children, with a variety of advanced cancers occurring in different sites of the body responded to larotrectinib, a novel therapy that targets a specific genetic mutation. Results of a phase 1/2 trial have been published in the New England Journal of Medicine. Unlike most cancer therapies, this oral treatment is based on the genetic traits of the tumor and not the organ where the cancer originated. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Kinase inhibitor larotrectinib shows durable anti-tumor abilities in patients of all ages with 17 un
(University of Texas M. D. Anderson Cancer Center) Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors with tropomyosin receptor kinase (TRK) fusions, gene mutations that switch on TRK genes, allowing cancer growth. The studies indicate larotrectinib as a potentially powerful new treatment approach for the approximately 5,000 patients with these forms of cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Drug successfully targets cancers with tumor-specific gene mutations
(Nemours) Pediatric and adult cancers with one of three fusion genes responds well to a new drug, larotrectinib, according to a study published today in the New England Journal of Medicine. The drug is designed to target a specific tumor gene mutation known as tropomyosin receptor kinases (TRK) that can occur in various tumor types. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Scientists discover new nanoparticle, dubbed exomeres
(Weill Cornell Medicine) A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body's intercellular delivery service to spread to new locations in the body. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

First 3-D digital models reveal the development of the extinct Tasmanian tiger
(University of Melbourne) Researchers from Museums Victoria and the University of Melbourne have CT scanned all 13 known Tasmanian tiger joey specimens to create 3-D digital models which have allowed them to study their skeletons and internal organs, and reconstruct their growth and development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Five novel genetic changes linked to pancreatic cancer risk
(Johns Hopkins Medicine) In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other institutions worldwide discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Breakthrough for peptide medication
(Technical University of Munich (TUM)) Peptides, short amino acid chains that control many functions in the human body, represent a billion-dollar market, also in the pharmaceutical industry. But, normally these medications must be injected. A research team led by the Technical University of Munich (TUM) has now determined how peptides can be designed so that they can be easily administered as a liquid or tablet. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

New interaction mechanism of proteins discovered
(University of Zurich) UZH researchers have discovered a previously unknown way in which proteins interact with one another and cells organize themselves. This new mechanism involves two fully unstructured proteins forming an ultra-high-affinity complex due to their opposite net charge. Proteins usually bind one another as a result of perfectly matching shapes in their three-dimensional structures. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Zika virus could help combat brain cancer
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Study by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults. Scientists foresee the use of genetic engineering to neutralize Zika virus' infectious whilst preserving the viral particles which induce the death of tumoral cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

New therapeutic gel shows promise against cancerous tumors
(University of North Carolina Health Care) Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results in animal models so far suggest this approach could one day ramp up therapeutic benefits for patients bearing tumors or after removal of the primary tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

How blood cancers outsmart the immune system
(American Association for the Advancement of Science) Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

'Local environment' plays key role in breast cancer progression
(Biophysical Society) Many of the drugs and therapies available today for treating breast cancer target the cancer cells but tend to neglect the surrounding 'local environment,' which includes surrounding tissues. But cancer cells and their local environment are connected, so both undergo chemical and physical changes during tumor development. During the 62nd Biophysical Society Meeting, researchers will present work exploring the role physical changes within a cancer cells' local environment play in the aggressiveness of breast cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 21, 2018 Category: Biology Source Type: news

Similarities found in cancer initiation in kidney, liver, stomach, pancreas
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis have found that when mature cells transition to begin dividing again, they all seem to do it the same way, regardless of what organ those cells come from. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2018 Category: International Medicine & Public Health Source Type: news

Study shows age doesn't affect survival in patients with non-Hodgkin lymphoma after HCT
(Be The Match) Results from a retrospective study presented at the 2018 BMT Tandem Meetings dispute age as a limiting factor to transplant eligibility, showing no differences in 4-year outcomes for patients older or younger than age 65. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

International team publishes roadmap to enhance radioresistance for space colonization
(Biogerontology Research Foundation) An international team of researchers from NASA Ames Research Center, Environmental and Radiation Health Sciences Directorate at Health Canada, Canadian Nuclear Laboratories, Belgian Nuclear Research Centre, Oxford University, Insilico Medicine, Insilico Medicine Taiwan, the Biogerontology Research Foundation, Boston University, Johns Hopkins University, University of Liverpool, University of Lethbridge, Ghent University, Center for Healthy Aging and many others have published a roadmap toward enhancing human radioresistance for space exploration and colonization. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

Cracking the connection between pediatric obesity and cancer
Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers — including pediatric cancers — obesity affects survival rates, which are lower for people who are obese.With an increasing population of overweight and obese children in the United States, researchers and physicians are racing to understand this connection – and what to do about it.Dr.Steven Mittelman, chief of pediatric endocrinology atUCLA Mattel Children ’s Hospital, is among those looking for clues to improve children ’s survival and recovery from cancer. But u...
Source: UCLA Newsroom: Health Sciences - February 21, 2018 Category: Universities & Medical Training Source Type: news

Adjuvant Chemo Still Has Value Beyond 6 Months After Colon Cancer Surgery Adjuvant Chemo Still Has Value Beyond 6 Months After Colon Cancer Surgery
Adjuvant chemotherapy has benefit even if given 6 months or more after resection for stage III colon cancer, a new retrospective study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 21, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Study: Fracking Fluids Alter Mice At 'Environmentally Relevant' Exposure Levels
AMHERST, Mass. - Researchers at the University of Massachusetts at Amherst and the University of Missouri-Columbia on Feb. 7 released a hydraulic fracturing study that suggests that the mammary gland in female mice is sensitive to mixtures of chemicals used in fracking at exposure levels that are "environmentally relevant." The researchers conclude that "the impact of these findings on the long-term health of the mammary gland, including its lactational capacity and its risk of cancer, should be evaluated in future studies." (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - February 21, 2018 Category: Medical Law Source Type: news

Cancer survival rate: What it means for your prognosis
No one can predict the future, but cancer survival rates can give you an idea of your prognosis. Should you pay attention to them? (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - February 21, 2018 Category: Consumer Health News Source Type: news

Facial Cancer Decimating Tasmanian Devil Population
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 21, 2018 Category: Cancer & Oncology Source Type: news

'I beat breast cancer - but side effects nearly killed me'
Virginia Harrod, 52, beat breast and thyroid cancers, but the Kentucky attorney and farmer could have been killed by her constant battle with an infection caused by a common treatment side effect. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2018 Category: Consumer Health News Source Type: news